Cargando…

Pancreatic cancer circulating tumour cells express a cell motility gene signature that predicts survival after surgery

BACKGROUND: Most cancer deaths are caused by metastases, resulting from circulating tumor cells (CTC) that detach from the primary cancer and survive in distant organs. The aim of the present study was to develop a CTC gene signature and to assess its prognostic relevance after surgery for pancreati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sergeant, Gregory, van Eijsden, Rudy, Roskams, Tania, Van Duppen, Victor, Topal, Baki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599097/ https://www.ncbi.nlm.nih.gov/pubmed/23157946 http://dx.doi.org/10.1186/1471-2407-12-527

Ejemplares similares

Perioperative cancer cell dissemination detected with a real-time RT-PCR assay for EpCAM is not associated with worse prognosis in pancreatic ductal adenocarcinoma
por: Sergeant, Gregory, et al.
Publicado: (2011)

Molecular markers associated with outcome and metastasis in human pancreatic cancer
por: Van den Broeck, Anke, et al.
Publicado: (2012)

Human Pancreatic Cancer Contains a Side Population Expressing Cancer Stem Cell-Associated and Prognostic Genes
por: Van den broeck, Anke, et al.
Publicado: (2013)

Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma
por: Janky, Rekin’s, et al.
Publicado: (2016)

Survival After Minimally Invasive vs Open Surgery for Pancreatic Adenocarcinoma
por: Topal, Halit, et al.
Publicado: (2022)

Human pancreatic adenocarcinoma contains a side population resistant to gemcitabine
por: Van den broeck, Anke, et al.
Publicado: (2012)

Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours
por: Sefrioui, David, et al.
Publicado: (2017)

Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA
por: Wu, Huanwen, et al.
Publicado: (2022)

YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role
por: Van Haele, Matthias, et al.
Publicado: (2019)

Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients
por: Weigelt, B, et al.
Publicado: (2003)

Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer
por: Ankeny, J S, et al.
Publicado: (2016)

Circulating Cell-Free Tumour DNA for Early Detection of Pancreatic Cancer
por: Jaworski, Jedrzej J., et al.
Publicado: (2020)

Single-cell motility and gene expression signature as predictors of the overall survival of act in melanoma patients
por: Martinez-Paniagua, Melisa, et al.
Publicado: (2015)

Tumour-derived exosomes as a signature of pancreatic cancer - liquid biopsies as indicators of tumour progression
por: Nuzhat, Zarin, et al.
Publicado: (2016)

Hyaluronan stimulates pancreatic cancer cell motility
por: Cheng, Xiao-Bo, et al.
Publicado: (2015)

Predictors of survival after surgery with curative intent for perihilar cholangiocarcinoma
por: Geers, Joachim, et al.
Publicado: (2020)

RNA sequencing of pancreatic circulating tumour cells implicates WNT signaling in metastasis
por: Yu, Min, et al.
Publicado: (2012)

Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells
por: Niizeki, H, et al.
Publicado: (2002)

Modelling Circulating Tumour Cells for Personalised Survival Prediction in Metastatic Breast Cancer
por: Ascolani, Gianluca, et al.
Publicado: (2015)

Squeezing through the microcirculation: survival adaptations of circulating tumour cells to seed metastasis
por: Perea Paizal, Julia, et al.
Publicado: (2020)

Brain tumour genetic network signatures of survival
por: Ruffle, James K, et al.
Publicado: (2023)

Clinical Applications of Circulating Tumour DNA in Pancreatic Adenocarcinoma
por: Loft, Matthew, et al.
Publicado: (2019)

Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer
por: Adamo, Patricia, et al.
Publicado: (2017)

Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
por: Sivapalan, Lavanya, et al.
Publicado: (2022)

Meta-Analysis of Human and Mouse Biliary Epithelial Cell Gene Profiles
por: Verhulst, Stefaan, et al.
Publicado: (2019)

Single-cell mRNA profiling reveals transcriptional heterogeneity among pancreatic circulating tumour cells
por: Lapin, Morten, et al.
Publicado: (2017)

Circulating tumour cells and tumour biomarkers in functional midgut neuroendocrine tumours
por: Meyer, Tim, et al.
Publicado: (2022)

Unbiased and Automated Identification of a Circulating Tumour Cell Definition That Associates with Overall Survival
por: Ligthart, Sjoerd T., et al.
Publicado: (2011)

Circulating tumour cells predict survival in gastric cancer patients: a meta-analysis
por: Wang, Hui-Yu, et al.
Publicado: (2016)

A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker
por: Khoja, L, et al.
Publicado: (2012)

Long term survival following the detection of circulating tumour cells in head and neck squamous cell carcinoma
por: Winter, Stuart C, et al.
Publicado: (2009)

The molecular detection of circulating tumour cells.
por: Johnson, P. W., et al.
Publicado: (1995)

Biosensors for the Detection of Circulating Tumour Cells
por: Costa, Clotilde, et al.
Publicado: (2014)

Circulating tumour cells in breast cancer
por: Krawczyk, Natalia, et al.
Publicado: (2013)

Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer—An Update
por: Kapeleris, Joanna, et al.
Publicado: (2022)

Circulating Tumour Cells: Detection and Application in Advanced Non-Small Cell Lung Cancer
por: Andrikou, Kalliopi, et al.
Publicado: (2023)

Keratin 19 marks poor differentiation and a more aggressive behaviour in canine and human hepatocellular tumours
por: van Sprundel, Renee GHM, et al.
Publicado: (2010)

C/EBPδ Suppresses Motility-Associated Gene Signatures and Reduces PDAC Cell Migration
por: Hartl, Leonie, et al.
Publicado: (2022)

Impact of the Nuclear Envelope on Malignant Transformation, Motility, and Survival of Lung Cancer Cells
por: Stefanello, Sílvio Terra, et al.
Publicado: (2021)

TCR repertoire and transcriptional signatures of circulating tumour‐associated T cells facilitate effective non‐invasive cancer detection
por: Ji, Fansen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i5b72dljtlun8fr6hl7pun480a